Search results for "Side effects"
Managing superbugs in your community
General internists are poised to assume a key role in tackling the increasingly formidable threat of antimicrobial resistance.
https://immattersacp.org/archives/2017/05/superbugs.htm
1 May 2017
First blood test approved to evaluate concussion
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/04/first-blood-test-approved-to-evaluate-concussion.htm
1 Apr 2018
Oncologist optimistic about latest cancer treatments
Genomic targeted therapies and immune therapies are 2 areas that internists should know about, so they can refer their patients for such treatments, an expert says.
https://immattersacp.org/archives/2015/07/cancer.htm
1 Jul 2015
Boxed warning removed from asthma drugs
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/03/boxed-warning-removed-from-asthma-drugs.htm
1 Mar 2018
‘Geriatric tsunami’ carries elderly obesity
By 2030, more than 20% of the U.S. population is expected to be over the age of 65, according to the U.S. Census Bureau. The expected rise in functional impairment in later years can be staved off with a healthy lifestyle.
https://immattersacp.org/archives/2017/02/elderly.htm
1 Feb 2017
New cardiovascular indication approved for diabetes drug
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/04/new-cardiovascular-indication-approved-for-diabetes-drug.htm
1 Apr 2022
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Recalls, research for generic drug safety
Probable carcinogens have been found in angiotensin-receptor blockers, but experts say generic drugs remain safe overall.
https://immattersacp.org/archives/2020/01/recalls-research-for-generic-drug-safety.htm
1 Jan 2020
Aiding patients' decisions on PSA screening
Routine prostate-specific antigen (PSA) screening of all men over a certain age began about 20 years ago, but the certainty about whether that was or is wise medical practice is long gone.
https://immattersacp.org/archives/2011/07/prostate.htm
1 Jul 2011
Managing Alzheimer's disease when options are limited
Primary care physicians can expect to diagnose an increasing number of patients with Alzheimer's disease as the U.S. population ages. While clinicians have been more successful in diagnosing the disease early, effective treatments or prevention options are more scarce.
https://immattersacp.org/archives/2016/03/alzheimers.htm
1 Mar 2016